1. Home
  2. EVO vs CLMT Comparison

EVO vs CLMT Comparison

Compare EVO & CLMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • CLMT
  • Stock Information
  • Founded
  • EVO 1993
  • CLMT 1916
  • Country
  • EVO Germany
  • CLMT United States
  • Employees
  • EVO N/A
  • CLMT N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • CLMT Oil & Gas Production
  • Sector
  • EVO Health Care
  • CLMT Energy
  • Exchange
  • EVO Nasdaq
  • CLMT Nasdaq
  • Market Cap
  • EVO 1.2B
  • CLMT 1.4B
  • IPO Year
  • EVO 2021
  • CLMT 2006
  • Fundamental
  • Price
  • EVO $3.48
  • CLMT $17.38
  • Analyst Decision
  • EVO Buy
  • CLMT Strong Buy
  • Analyst Count
  • EVO 2
  • CLMT 6
  • Target Price
  • EVO $5.40
  • CLMT $20.38
  • AVG Volume (30 Days)
  • EVO 52.1K
  • CLMT 908.1K
  • Earning Date
  • EVO 11-05-2025
  • CLMT 11-07-2025
  • Dividend Yield
  • EVO N/A
  • CLMT N/A
  • EPS Growth
  • EVO N/A
  • CLMT N/A
  • EPS
  • EVO N/A
  • CLMT N/A
  • Revenue
  • EVO $912,894,891.00
  • CLMT $4,070,400,000.00
  • Revenue This Year
  • EVO $0.43
  • CLMT $1.02
  • Revenue Next Year
  • EVO $9.72
  • CLMT $2.01
  • P/E Ratio
  • EVO N/A
  • CLMT N/A
  • Revenue Growth
  • EVO N/A
  • CLMT N/A
  • 52 Week Low
  • EVO $2.84
  • CLMT $7.68
  • 52 Week High
  • EVO $5.64
  • CLMT $25.29
  • Technical
  • Relative Strength Index (RSI)
  • EVO 39.62
  • CLMT 64.53
  • Support Level
  • EVO $3.36
  • CLMT $16.00
  • Resistance Level
  • EVO $3.52
  • CLMT $16.58
  • Average True Range (ATR)
  • EVO 0.08
  • CLMT 0.84
  • MACD
  • EVO 0.00
  • CLMT 0.30
  • Stochastic Oscillator
  • EVO 31.58
  • CLMT 88.45

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About CLMT Calumet Specialty Products Partners L.P. Common Units

Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.

Share on Social Networks: